MAURI, MARIO
MAURI, MARIO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
2025 Saettini, F; Guerra, F; Mauri, M; Salter, C; Adam, M; Adams, D; Baple, E; Barredo, E; Bhatia, S; Borkhardt, A; Brusco, A; Bugarin, C; Chinello, C; Crosby, A; D'Souza, P; Denti, V; Fazio, G; Giuliani, S; Kuehn, H; Amel, H; Elmi, A; Lo, B; Malighetti, F; Mandrile, G; Martín-Nalda, A; Mefford, H; Moratto, D; Emam Mousavi, F; Nelson, Z; Gutiérrez-Solana, L; Macnamara, E; Michaud, V; O'Leary, M; Pagani, L; Pavinato, L; Santamaria, P; Planas-Serra, L; Quadri, M; Raspall-Chaure, M; Rebellato, S; Rosenzweig, S; Roubertie, A; Holzinger, D; Deal, C; Vockley, C; Savino, A; L. Stoddard, J; Uhlig, H; Pujol, A; Magni, F; Paglia, G; Cazzaniga, G; Piazza, R; Barberis, M; Biondi, A
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model
2024 Corbetta, P; Lonati, E; Pagliari, S; Mauri, M; Cazzaniga, E; Botto, L; Campone, L; Palestini, P; Bulbarelli, A
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma
2024 Villa, M; Geeta, G; Malighetti, F; Mauri, M; Arosio, G; Cordani, N; Lobello, C; Larose, H; Pirola, A; D'Aliberti, D; Massimino, L; Criscuolo, L; Pagani, L; Chinello, C; Mastini, C; Fontana, D; Bombelli, S; Meneveri, R; Lovisa, F; Mussolin, L; Janikova, A; Pospíšilová, Š; Turner, S; Inghirami, G; Magni, F; Urso, M; Pagni, F; Ramazzotti, D; Piazza, R; Chiarle, R; Gambacorti-Passerini, C; Mologni, L
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet
2023 Difrancesco, J; Ragona, F; Murano, C; Frosio, A; Melgari, D; Binda, A; Calamaio, S; Prevostini, R; Mauri, M; Canafoglia, L; Castellotti, B; Messina, G; Gellera, C; Previtali, R; Veggiotti, P; Milanesi, R; Barbuti, A; Solazzi, R; Freri, E; Granata, T; Rivolta, I
Antibody Deficiency in Patients with Biallelic KARS1 Mutations
2023 Saettini, F; Guerra, F; Fazio, G; Bugarin, C; Mcmillan, H; Ohtake, A; Ardissone, A; Itoh, M; Giglio, S; Cappuccio, G; Giardino, G; Romano, R; Quadri, M; Gasperini, S; Moratto, D; Chiarini, M; Akira, I; Fukuhara, Y; Hayakawa, I; Okazaki, Y; Mauri, M; Piazza, R; Cazzaniga, G; Biondi, A
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
2023 Cordani, N; Lisini, D; Cocce, V; Paglia, G; Meanti, R; Cerrito, M; Tettamanti, P; Bonaffini, L; Paino, F; Alessandri, G; Marcianti, A; Gianni, A; Villa, C; Mauri, M; Mologni, L; Torsello, A; Pessina, A; Cazzaniga, M
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7)
2023 Saettini, F; Guerra, F; Fazio, G; Bugarin, C; Mcmillan, H; Ohtake, A; Ardissone, A; Itoh, M; Giglio, S; Cappuccio, G; Giardino, G; Romano, R; Quadri, M; Gasperini, S; Moratto, D; Chiarini, M; Ishiguro, A; Fukuhara, Y; Hayakawa, I; Okazaki, Y; Mauri, M; Piazza, R; Cazzaniga, G; Biondi, A
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
2023 Malighetti, F; Arosio, G; Manfroni, C; Mauri, M; Villa, M; Manghisi, B; Inzoli, E; Rindone, G; Zambrotta, G; Civettini, I; Guglielmana, V; Ramazzotti, D; Giudici, G; Bombelli, S; Perego, R; Piazza, R; Mologni, L; Gambacorti-Passerini, C
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia
2023 Aroldi, A; Mauri, M; Ramazzotti, D; Villa, M; Malighetti, F; Crippa, V; Cocito, F; Borella, C; Bossi, E; Steidl, C; Scollo, C; Voena, C; Chiarle, R; Mologni, L; Piazza, R; Gambacorti Passerini, C
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
2023 Cordani, N; Mologni, L; Piazza, R; Tettamanti, P; Cogliati, V; Mauri, M; Villa, M; Malighetti, F; DI BELLA, C; Jaconi, M; Cerrito, M; Cavaletti, G; Lavitrano, M; Cazzaniga, M
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis
2022 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Manghisi, B; Cavalca, F; Ripamonti, A; Brioschi, F; Palamini, S; Mottadelli, F; Ramazzotti, D; Piperno, A; Gambacorti Passerini, C; Piazza, R
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution
2022 Ramazzotti, D; Angaroni, F; Maspero, D; Mauri, M; D’Aliberti, D; Fontana, D; Antoniotti, M; Elli, E; Graudenzi, A; Piazza, R
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency
2021 Saettini, F; Poli, C; Vengoechea, J; Bonanomi, S; Orellana, J; Fazio, G; Rodriguez III, F; Noguera, L; Booth, C; Jarur-Chamy, V; Shams, M; Iascone, M; Vukic, M; Gasperini, S; Quadri, M; Seijas, A; Rivers, E; Mauri, M; Badolato, R; Cazzaniga, G; Bugarin, C; Gaipa, G; Kroes, W; Moratto, D; van Oostaijen-Ten Dam, M; Baas, F; van der Maarel, S; Piazza, R; Coban-Akdemir, Z; Lupski, J; Yuan, B; Chinn, I; Daxinger, L; Biondi, A
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis
2021 Saettini, F; Fazio, G; Moratto, D; Galbiati, M; Zucchini, N; Ippolito, D; Dinelli, M; Imberti, L; Mauri, M; Melzi, M; Bonanomi, S; Gerussi, A; Pinelli, M; Barisani, C; Bugarin, C; Chiarini, M; Giacomelli, M; Piazza, R; Cazzaniga, G; Invernizzi, P; Giliani, S; Badolato, R; Biondi, A
Hif1a: A putative modifier of hemochromatosis
2021 Pelucchi, S; Ravasi, G; Arosio, C; Mauri, M; Piazza, R; Mariani, R; Piperno, A
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma
2021 Arosio, G; Sharma, G; Villa, M; Mauri, M; Crespiatico, I; Fontana, D; Manfroni, C; Mastini, C; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Massimino, L; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models
2021 Sharma, G; Arosio, G; Villa, M; Mauri, M; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Crespiatico, I; Fontana, D; Mastini, C; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L